Pulmonology

Papers
(The H4-Index of Pulmonology is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)
ArticleCitations
“ Gallia est omnis divisa in partes tres ”: Is it time to divide Pleuroparenchymal Fibroelastosis in three different forms?61
Smoking exposure trajectories and pulmonary function in early adulthood in a Brazilian cohort61
Issue 2 - “Update on adverse respiratory effects of indoor air pollution”. Part 2): Indoor air pollution and respiratory diseases: Perspectives from Italy and some other GARD countries56
High-dose inhaled NO for the prevention of nosocomial pneumonia after cardiac surgery under cardiopulmonary bypass: A proof-of-concept prospective randomised study55
Reproducibility, validity, and reliability of the incremental step test for subjects with moderate to severe asthma51
Intra- and interobserver agreement of inspiratory capacity during cardio pulmonary exercise test39
Effect of elexacaftor–tezacaftor–ivacaftor modulator on lung structure in cystic fibrosis38
Single breath nitrogen test as predictor of lung function decline and COPD over an 8-year follow-up38
Mixed squamous cell and glandular papilloma of the bronchus33
Intensity of exercise in people with COPD enrolled in community-based physical activities33
Late-onset Pompe disease (LOPD): May axial myopathy influence respiratory dysfunction?31
Exposed posters30
The Vacinómetro® initiative: an eleven-year monitorization of influenza vaccination coverage rates among risk groups in Portugal30
Effects of asymmetric nasal high-flow cannula on carbon dioxide in hypercapnic patients: A randomised crossover physiological pilot study29
Flow-controlled ventilation may reduce mechanical power and increase ventilatory efficiency in severe coronavirus disease-19 acute respiratory distress syndrome29
Ultrasound-guided needle aspiration biopsy of isolated anterior mediastinal masses26
What do we know about macrolides immunomodulatory therapeutic potential in respiratory disease in 202326
Diaphragm thickening fraction and inspiratory effort in patients with SARS-COV II pneumonia receiving different non-invasive respiratory supports26
Geographical variation in lung function: Results from the multicentric cross-sectional BOLD study26
Chylothorax as an unusual presentation of Bosutinib therapy toxicity25
Blood pressure and sleep during a 12-month stay at Concordia Station (3233 m), Antarctica24
Regarding the prognostic factors in patients with ALK-positive non-small cell lung cancer treated with crizotinib24
Differences in exercise capacity and health-related quality of life according to the body mass index in patients with COPD24
A study of the psychometric properties of the Brazilian–Portuguese version of Bronchiectasis Health Questionnaire23
Prevascular mediastinal angyomiolipoma. A case report23
The public health impact of e-cigarette use: Revisiting Geoffrey Rose's prevention strategies23
0.10175800323486